184 related articles for article (PubMed ID: 26560124)
1. CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.
Peng B; Chai Y; Li Y; Liu X; Zhang J
BMC Cancer; 2015 Nov; 15():895. PubMed ID: 26560124
[TBL] [Abstract][Full Text] [Related]
2. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.
Lei N; Peng B; Zhang JY
Oncol Rep; 2014 Oct; 32(4):1689-94. PubMed ID: 25109354
[TBL] [Abstract][Full Text] [Related]
3. CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer.
Peng B; Lei N; Chai Y; Chan EK; Zhang JY
Mol Biosyst; 2015 Jan; 11(1):105-14. PubMed ID: 25325377
[TBL] [Abstract][Full Text] [Related]
4. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
[TBL] [Abstract][Full Text] [Related]
5. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
6. Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer.
Ma L; Wen ZS; Liu Z; Hu Z; Ma J; Chen XQ; Liu YQ; Pu JX; Xiao WL; Sun HD; Zhou GB
PLoS One; 2011; 6(5):e20159. PubMed ID: 21655278
[TBL] [Abstract][Full Text] [Related]
7. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
[TBL] [Abstract][Full Text] [Related]
8. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes.
Nishitani K; Ito H; Hiramitsu T; Tsutsumi R; Tanida S; Kitaori T; Yoshitomi H; Kobayashi M; Nakamura T
J Cell Biochem; 2010 Feb; 109(2):425-33. PubMed ID: 19998410
[TBL] [Abstract][Full Text] [Related]
9. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
11. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
12. Estradiol enhances CIP2A expression by the activation of p70 S6 kinase.
Choi YA; Koo JS; Park JS; Park MY; Jeong AL; Oh KS; Yang Y
Endocr Relat Cancer; 2014 Apr; 21(2):189-202. PubMed ID: 24280132
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway.
Zapata HJ; Nakatsugawa M; Moffat JF
J Virol; 2007 Jan; 81(2):977-90. PubMed ID: 17079291
[TBL] [Abstract][Full Text] [Related]
14. Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.
Nakagawa K; Sugahara M; Yamasaki T; Kajiho H; Takahashi S; Hirayama J; Minami Y; Ohta Y; Watanabe T; Hata Y; Katada T; Nishina H
Biochem J; 2010 Mar; 427(2):237-45. PubMed ID: 20156194
[TBL] [Abstract][Full Text] [Related]
15. Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.
Yoshizawa T; Hammaker D; Sweeney SE; Boyle DL; Firestein GS
J Immunol; 2008 Sep; 181(5):3252-8. PubMed ID: 18713996
[TBL] [Abstract][Full Text] [Related]
16. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
17. IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma.
Sung WW; Wang YC; Lin PL; Cheng YW; Chen CY; Wu TC; Lee H
Clin Cancer Res; 2013 Aug; 19(15):4092-103. PubMed ID: 23743567
[TBL] [Abstract][Full Text] [Related]
18. Activation of the c-Jun NH
Fung TS; Liu DX
Cell Death Dis; 2017 Dec; 8(12):3215. PubMed ID: 29238080
[TBL] [Abstract][Full Text] [Related]
19. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
[TBL] [Abstract][Full Text] [Related]
20. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
